Health Care & Life Sciences » Biotechnology | Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 6.53 M
Public Float
 -
Santhera Pharmaceuticals Holding AG
Stock Exchange SIX Swiss Exchange
EPS
 CHF7.86
Market Cap
 CHF169.34 M
Shares Outstanding
 11.16 M
Public Float
 8.21 M

Profile

Address
Hohenrainstrasse 24
Pratteln Basel-Landschaft (Basle Country) 4133
Switzerland
Employees -
Website http://www.santhera.com
Updated 07/08/2019
Santhera Pharmaceuticals Holding AG is a pharmaceutical company. It engages in the development, marketing, and commercialization of pharmaceutical products for the treatment of neuro-ophthalmological, neuromuscular, and pulmonary diseases. It offers its products under the Raxone brands.

Financials

View All
Created with Highcharts 5.0.14Santhera Pharmaceuticals Holding AGNet Income. Fiscal year is January-December. All values CHF Thousands.5 7555 7557 9527 9525 9495 94935 41535 41551 53251 53254 18654 186201320142015201620172018010k20k30k40k50k60k
Created with Highcharts 5.0.14Santhera Pharmaceuticals Holding AGSales/Revenue. Fiscal year is January-December. All values CHF Thousands.1 3191 3192 5912 5914 3214 32119 03319 03322 94322 94331 65731 657201320142015201620172018010k20k30k40k

Thomas Meier
Chief Executive Officer & Director
Martin Gertsch
Vice Chairman
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.